About Nakanishi, Inc. 
Nakanishi, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.04%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
22,489 Million
(Quarterly Results - Mar 2026)
Net Profit:
3,980 Million
Pharmaceuticals & Biotechnology
JPY 281,266 Million (Small Cap)
23.00
NA
0.00%
-0.24
12.82%
2.42






